K. Kümmerer, A. Henninger Clinical Microbiology and Infection

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995 Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

P. Davey, C. Pagliari, A. Hayes Clinical Microbiology and Infection

F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription B. Maraha, M. Bonten, H. Fiolet,

N.C. Weightman, S. Mitra, P.T. Kipling

Structure of grepafloxacin relative to activity and safety profile

Vector control: a cornerstone in the malaria elimination campaign

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.

Training for the infectious diseases speciality in Norway

B. Gordts Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Levofloxacin in the treatment of ventilator-associated pneumonia

Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens* M. Kanellopoulou, A. Makri,

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

Pathogenesis of catheter-related infections: lessons for new designs

Systematic review of antibiotic consumption in acute care hospitals

Antibacterial drug discovery in the 21st century

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Training in infectious diseases and tropical medicine in Britain

Definition of the Clinical Antibacterial Spectrum of Activity

Clinical infection services—the Leiden experience

Training in infectious diseases—looking to the future

Clinical Microbiology and Infection

Clinical Microbiology and Infection

W. Eugene Sanders, Christine C. Sanders

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Clinical and molecular epidemiology of chromosome-mediated resistance to third- generation cephalosporins in Enterobacter isolates in eastern France D.

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

In vitro activity of evernimicin and selected antibiotics against methicillin-resistant staphylococci: a 24-country study R. Goering, C.-E. Nord, R.

A. Manzur, F. Gudiol Clinical Microbiology and Infection

Antibiotic resistance of Helicobacter pylori: a cross-sectional study in consecutive patients, and relation to ethnicity R.J.L.F. Loffeld, C.A.P.M.J.

Carratalà J. Clinical Microbiology and Infection

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands J.W. Mouton, A.R. Jansz Clinical.

N.C. Weightman, S. Mitra, P.T. Kipling

Typing of Clostridium difficile

New patterns of HIV-1 resistance during HAART

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

Abstracts Clinical Microbiology and Infection

Localized Mycobacterium avium complex infection in a patient on HAART

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Promoting resistance by the emission of antibiotics from hospitals and households into effluent K. Kümmerer, A. Henninger Clinical Microbiology and Infection Volume 9, Issue 12, Pages 1203-1214 (December 2003) DOI: 10.1111/j.1469-0691.2003.00739.x Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Scheme of calculation procedure. Clinical Microbiology and Infection 2003 9, 1203-1214DOI: (10.1111/j.1469-0691.2003.00739.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Release of antibiotics into effluent in Germany according to groups; excretion rates included. Clinical Microbiology and Infection 2003 9, 1203-1214DOI: (10.1111/j.1469-0691.2003.00739.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 3 Quantity of antibiotics emitted into municipal waste water, according to origin (excretion rates included). Clinical Microbiology and Infection 2003 9, 1203-1214DOI: (10.1111/j.1469-0691.2003.00739.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions